Systematic review and network meta-analysis for the 2026 update of the evidence-based clinical practice guidelines for the management with immunosuppressive therapies and biologic agents of membranous nephropathy

发表于 2026-9-27 14:32:49

期刊：Clinical and Experimental Nephrology

文献作者：Reiji Takami; Hiroki Nishiwaki; Yasushi Tsujimoto; Yuji Oe; Keisuke Onishi; Yuki Oba; Shinnosuke Sugihara; Yoshitaka Miyaoka; Mai Yoshida; Masahiko Yazawa; Tadashi Sofue; Izaya Nakaya; Takuji Ishimoto; Takehiko Kawaguchi; Noriaki Kurita; Sayaka Shimizu; Kengo Furuichi; Hirokazu Okada; Takehiko Wada

出版日期：--

DOI号：10.1007/s10157-026-02944-4

下载链接：https://link.springer.com/conten ... 157-026-02944-4.pdf

文献链接：https://doi.org/10.1007/s10157-026-02944-4

当前文献来源于 Springer Science and Business Media LLC。

备注信息：

发表于 2026-9-27 14:32:50

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Springer] Systematic review and network meta-analysis for the 2026 update of the evidence-based clinical practice guidelines for the management with immunosuppressive therapies and biologic agents of membranous nephropathy

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Springer] Systematic review and network meta-analysis for the 2026 update of the evidence-based clinical practice guidelines for the management with immunosuppressive therapies and biologic agents of membranous nephropathy 一键复制

已采纳